Maen Abou Ziki, MD

Maen D. Abou Ziki, MD is a Fellow in Cardiovascular Medicine at Yale University/Yale New Haven Medical Center. He graduated with honors in research from the Qatar campus of the Weill Cornell Medical College of Cornell University prior to starting his internal medicine residency at Yale University in June 2014.

Since medical school, Dr. Abou Ziki has been involved in genetic medicine research with projects encompassing genomics and gene therapy. His current projects focus on genetic modifiers for atherosclerotic coronary artery disease, and arrhythmogenic conditions such as long QT syndrome and heart block. He has also collaborated with several research groups on studies of thromboembolic disease and outcomes research in heart failure patients.

Dr. Abou Ziki's cardiovascular genetics research will contribute towards better screening and cardiovascular risk stratification, in addition to advancing our molecular understanding of disease pathways.

Furthermore, Dr. Abou Ziki has strong interest in the complex social, ethical, and legal questions that advances in genetic technology have given rise to. For instance, the consequences of genome editing with CRISPR are currently dominated by uncertainty. The concerns for misuse are not only ethical but also touch upon human rights, security, and geopolitics. This is one of many rapidly changing landscapes that will benefit from physician-scientist leadership to help guide the responsible use of these technologies, and their ethical application in humans against discriminatory practices. He currently serves a distinguished medical scholar in residence at the Solomon Center for Health Law and Policy at the Yale Law School.